Literature DB >> 10581365

Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies.

F J Sharom1, R Liu, Y Romsicki, P Lu.   

Abstract

The P-glycoprotein multidrug transporter is a 170-kDa efflux pump which exports a diverse group of natural products, chemotherapeutic drugs, and hydrophobic peptides across the plasma membrane, driven by ATP hydrolysis. The transporter has been proposed to interact with its drug substrates within the membrane environment; however, much remains to be learned about the nature and number of the drug binding site(s). The two nucleotide binding domains are responsible for ATP binding and hydrolysis, which is coupled to drug movement across the membrane. In recent years, P-glycoprotein has been purified and functionally reconstituted in amounts large enough to allow biophysical studies. The use of spectroscopic techniques has led to insights into both its secondary and tertiary structure, and its interaction with nucleotides and drugs. In this review, we will summarise what has been learned by application to purified P-glycoprotein of fluorescence spectroscopy, circular dichroism spectroscopy and infra-red spectroscopy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581365     DOI: 10.1016/s0005-2736(99)00166-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism.

Authors:  H W van Veen; A Margolles; M Müller; C F Higgins; W N Konings
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 2.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 3.  The mechanism of action of multidrug-resistance-linked P-glycoprotein.

Authors:  Z E Sauna; M M Smith; M Müller; K M Kerr; S V Ambudkar
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

4.  The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids.

Authors:  Paul D W Eckford; Frances J Sharom
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

5.  Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P-glycoprotein-related activities.

Authors:  Karsten Bucher; Camille A Besse; Sarah W Kamau; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

6.  Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.

Authors:  Kaitlyn V Ledwitch; Morgan E Gibbs; Robert W Barnes; Arthur G Roberts
Journal:  Biochem Pharmacol       Date:  2016-08-13       Impact factor: 5.858

7.  Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.

Authors:  Dana Emmert; Christopher R Campos; David Ward; Peihua Lu; Hilda A Namanja; Kelsey Bohn; David S Miller; Frances J Sharom; Jean Chmielewski; Christine A Hrycyna
Journal:  ACS Chem Neurosci       Date:  2014-02-07       Impact factor: 4.418

8.  Purification and characterization of the membrane-bound complex of an ABC transporter, the histidine permease.

Authors:  G F Ames; K Nikaido; I X Wang; P Q Liu; C E Liu; C Hu
Journal:  J Bioenerg Biomembr       Date:  2001-04       Impact factor: 2.945

9.  Substrate binding by a bacterial ABC transporter involved in polysaccharide export.

Authors:  Leslie Cuthbertson; Matthew S Kimber; Chris Whitfield
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

10.  Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis.

Authors:  Alena Siarheyeva; Ronghua Liu; Frances J Sharom
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.